Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation

Biochemical and Biophysical Research Communications

Volumn 414, Issue 1, 2011, Pages 118-122

  Massa, Fabienne ^a   Tormo, Aurélie ^a   Béraud Dufour, Sophie ^a   Coppola, Thierry ^a   Mazella, Jean ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cancer cell; Growth factor; MAP kinases; Neurotensin; Proliferation

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTENSIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADENOCARCINOMA; CELL PROLIFERATION; COLONIC NEOPLASMS; EPIDERMAL GROWTH FACTOR; HCT116 CELLS; HT29 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROTENSIN; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, NEUROTENSIN;

EID: 80054076451     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.034     Document Type: Article

References (20)

1. Pai R., Soreghan B., Szabo I.L., Pavelka M., Baatar D., Tarnawski A.S. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 2002, 8:289-293.
2. Reubi J.C. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003, 24:389-427.
3. Rozengurt E. Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol. Metab. 2002, 13:128-134.
4. Vincent J.P., Mazella J., Kitabgi P. Neurotensin and neurotensin receptors. Trends Pharmacol. Sci. 1999, 20:302-309.
5. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., Ferrara P., Vita N., Gully D., Maffrand J.P., Vincent J.P. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 1998, 273:26273-26276.
6. Petersen C.M., Nielsen M.S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H.H., Roigaard H., Gliemann J., Madsen P., Moestrup S.K. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J. Biol. Chem. 1997, 272:3599-3605.
7. Ehlers R.A., 2nd, Bonnor R.M., Wang X., Hellmich M.R., Evers B.M. Signal transduction mechanisms in neurotensin-mediated cellular regulation. Surgery 1998, 124:239-246; discussion 246-237.
8. Zhao D., Zhan Y., Koon H.W., Zeng H., Keates S., Moyer M.P., Pothoulakis C. Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells. J. Biol. Chem. 2004, 279:43547-43554.
9. Zhao D., Bakirtzi K., Zhan Y., Zeng H., Koon H.W., Pothoulakis C. Insulin-like growth factor-1 receptor transactivation modulates the inflammatory and proliferative responses of neurotensin in human colonic epithelial cells. J. Biol. Chem. 2011, 286:6092-6099.
10. Martin S., Navarro V., Vincent J.P., Mazella J. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. Gastroenterology 2002, 123:1135-1143.
11. Navarro V., Martin S., Mazella J. Internalization-dependent regulation of HT29 cell proliferation by neurotensin. Peptides 2006, 27:2502-2507.
12. Comens P.G., Simmer R.L., Baker J.B. Direct linkage of 125I-EGF to cell surface receptors. A useful artifact of chloramine-T treatment. J. Biol. Chem. 1982, 257:42-45.
13. Botto J.M., Chabry J., Sarret P., Vincent J.P., Mazella J. Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism. Biochem. Biophys. Res. Commun. 1998, 243:585-590.
14. Beraud-Dufour S., Abderrahmani A., Noel J., Brau F., Waeber G., Mazella J., Coppola T. Neurotensin is a regulator of insulin secretion in pancreatic beta-cells. Int. J. Biochem. Cell Biol. 2010, 42:1681-1688.
15. Bozou J.C., Rochet N., Magnaldo I., Vincent J.P., Kitabgi P. Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem. J. 1989, 264:871-878.
16. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 1991, 266:15771-15781.
17. Islam M.S., Kindmark H., Larsson O., Berggren P.O. Thiol oxidation by 2,2'-dithiodipyridine causes a reversible increase in cytoplasmic free Ca2+ concentration in pancreatic beta-cells. Role for inositol 1,4,5-trisphosphate-sensitive Ca2+ stores. Biochem. J. 1997, 321(Pt 2):347-354.
18. Poinot-Chazel C., Portier M., Bouaboula M., Vita N., Pecceu F., Gully D., Monroe J.G., Maffrand J.P., Le Fur G., Casellas P. Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. Biochem. J. 1996, 320(Pt 1):145-151.
19. Hassan S., Dobner P.R., Carraway R.E. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. Regul. Pept. 2004, 120:155-166.
20. Guha S., Lunn J.A., Santiskulvong C., Rozengurt E. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Cancer Res. 2003, 63:2379-2387.